Li I Liu from Germantown, MD, age 62

Resumes

Li Liu Washington, DC

view source

Work:

Strain & Strain PLLC

Sep 2013 to 2000
Legal Intern Wealth Strategies Journal

Aug 2013 to 2000
Associate Editor U.S. Securities and Exchange Commission
Washington, DC
Jan 2013 to May 2013
Legal Extern Siemens Ltd. China, Legal Department

Apr 2012 to Jul 2012
Assistant Counsel Intermediate People's Court of Zhangzhou City

Aug 2011 to Aug 2011
Chief Judge's Assistant Yi Lian Law Aid Center

Mar 2011 to Jun 2011
Volunteer Counsel Concord & Partners Law Firm

Jun 2010 to Jul 2010
Legal Intern

Education:

Georgetown University Law Center
Washington, DC
2013
Master of Laws Tsinghua University
2008 to 2012
Bachelor of Laws

Skills:

legal research, legal writing, analysis, Chinese, Taiwanese

Medicine Doctors

Dr. Li Liu, Washington DC - MD (Doctor of Medicine)

view source

Specialties:

Anatomic & Clinical Pathology

Address:

3800 Reservoir Rd Nw, Washington, DC 20007
2026873614 (Phone), 8773031460 (Fax)

Languages:

English

Li M. Liu

view source

Specialties:

Hematology/Oncology, Internal Medicine

Work:

Lebanon VA Medical Center Surgical Clinic
1700 S Lincoln Ave, Lebanon, PA 17042
7172726621 (phone), 7172286118 (fax)

Education:

Medical School
Sun Yat Sen Univ of Med Sci, Guangzhou, China (242 21 Pr 1/71)
Graduated: 1982

Procedures:

Bone Marrow Biopsy
Chemotherapy

Conditions:

Anemia
Iron Deficiency Anemia
Non-Hodgkin's Lymphoma
Breast Neoplasm, Malignant
Hemolytic Anemia

Languages:

English

Description:

Dr. Liu graduated from the Sun Yat Sen Univ of Med Sci, Guangzhou, China (242 21 Pr 1/71) in 1982. He works in Lebanon, PA and specializes in Hematology/Oncology and Internal Medicine. Dr. Liu is affiliated with Lebanon VA Medical Center.

Li Liu

view source

Specialties:

Radiation Oncology

Work:

Fresno Cancer Center
7887 N Cedar Ave, Fresno, CA 93720
5594371000 (phone), 5594373870 (fax)

Education:

Medical School
Beijing Med Univ, Beijing City, Beijing, China
Graduated: 1987

Languages:

English
Spanish

Description:

Dr. Liu graduated from the Beijing Med Univ, Beijing City, Beijing, China in 1987. He works in Fresno, CA and specializes in Radiation Oncology.

Li Liu

view source

Specialties:

Internal Medicine

Work:

Garfield Health Center
210 N Garfield Ave STE 203, Monterey Park, CA 91754
6263077397 (phone), 6263071807 (fax)

Education:

Medical School
Hunan Med Univ, Changsha City, Hunan, China
Graduated: 1985

Languages:

Chinese
English
Spanish
Vietnamese

Description:

Dr. Liu graduated from the Hunan Med Univ, Changsha City, Hunan, China in 1985. She works in Monterey Park, CA and specializes in Internal Medicine. Dr. Liu is affiliated with Garfield Medical Center and Pacific Alliance Medical Center.

Li Liu

view source

License Records

Li Liu

License #:

27485 - Active

Issued Date:

Apr 26, 2010

Expiration Date:

Jun 30, 2017

Type:

Certified Public Accountant

Li Liu

License #:

06971 - Active

Category:

Accountants

Issued Date:

Oct 1, 2014

Expiration Date:

Jun 30, 2018

Type:

Certified Public Accountant

Li Liu

License #:

06971 - Active

Category:

Accountants

Issued Date:

Oct 1, 2014

Expiration Date:

Jun 30, 2018

Type:

Certified Public Accountant

Li Min Liu

License #:

MT036825T - Expired

Category:

Medicine

Type:

Graduate Medical Trainee

Isbn (Books And Publications)

The Chinese Neolithic: Trajectories To Early States

view source

Author
Li Liu

ISBN #
0521811848

State Formation in Early China

view source

Author
Li Liu

ISBN #
0715632248

Les Erreurs Des etudiants Chinois Dans L'apprentissage Du Francais

view source

Author
Li Liu

ISBN #
2892191971

Name / Title

Company / Classification

Phones & Addresses

Li Xia (Virginia) Liu
Ms

Cityscene Electric Ltd
Electric Contractors

17 2615 Shaftsbury Ave, Port Coquitlam, BC V3C 6N1
6049681524

Li Liu
Chairman of the Board, Chief Executive Officer, Chief Financial Officer

China Education International, Inc
Business Consulting Services · Elementary/Secondary School School/Educational Services · Elementary/Secondary Schools Educational Services · Management Services

105 Maxess Rd, Huntington Station, NY 11747
48 Wall St, New York, NY 10005
665 Ellsworth Ave, New Haven, CT 06511

Li Xia Liu
Ms

Cityscene Electric Ltd
Electric Contractors

6049681524

Li Juan Liu
Owner

New Ocean Chinese Restaurant
Chinese Restaurant

1128 E Luzerne St, Philadelphia, PA 19124
2152887871

Li Liu
Principal

Jili Lab
Nonclassifiable Establishments

1504 Isaacs Ct, Prospectville, PA 19002

Li Liu
Principal

Liu, Li Cai
Business Services at Non-Commercial Site

1100 Vine St, Philadelphia, PA 19107

Us Patents

Compounds And Method For Preparing Substituted 4-Phenyl-4-Cyanocyclohexanoic Acids
view source
US Patent:

6337408, Jan 8, 2002
Filed:

Mar 22, 2000
Appl. No.:

09/533368
Inventors:

Andrew Allen - Exton PA
Ann Marie Diederich - Downingtown PA
Li Liu - Collegeville PA
Wilford Mendelson - King of Prussia PA
Kevin Webb - Phoenixville PA
Assignee:

SmithKline Beecham Corporation - Philadelphia PA
International Classification:

C07D30300
US Classification:

549332, 560 59, 558409, 564163
Abstract:

This invention relates to a method of preparing a compound of the following type by treating a compound of formula (II) with lithium bromide, magnesium bromide and the like.

Method For Screening Compounds For The Treatment Of Neoplasia
view source
US Patent:

6569638, May 27, 2003
Filed:

Mar 3, 2000
Appl. No.:

09/517734
Inventors:

I. Bernard Weinstein - Englewood NJ
W. Joseph Thompson - Doylestown PA
Jae-Won Soh - Cliffside Park NJ
Li Liu - Ambler PA
Han Li - Yardley PA
Assignee:

Cell Pathways, Inc - Horsham PA
International Classification:

C12Q 148
US Classification:

435 15, 435 692, 435184
Abstract:

This invention provides a method to identify compounds potentially useful for the treatment and prevention of neoplasia in mammals. The phosphodiesterase inhibitory activity of a compound is determined along with its ability to elevate JNK kinase activity. Growth inhibitory and apoptosis inducing effects on cultured tumor cells are also determined. Compounds that exhibit phosphodiesterase inhibition, an ability to elevate JNK kinase activity, growth inhibition and apoptosis induction are desirable for the treatment of neoplasia.

Triazoles As Farnesyl Transferase Inhibitors
view source
US Patent:

7049324, May 23, 2006
Filed:

Nov 15, 2000
Appl. No.:

10/130322
Inventors:

Ashis Kumar Saha - Harleysville PA, US
David William End - Ambler PA, US
Bart Lieven Daniel De Corte - Southampton PA, US
Henry Joseph Breslin - Lansdale PA, US
Li Liu - Doylestown PA, US
International Classification:

A61K 31/47
C07D 215/38
C07D 249/08
US Classification:

514311, 5482622, 5482676, 546169, 514383
Abstract:

p-00010000.

Piperdinyl-Phenoxazine And Phenothiazine Derivatives As Δ-Opioid Modulators
view source
US Patent:

7432257, Oct 7, 2008
Filed:

Jan 5, 2006
Appl. No.:

11/326084
Inventors:

Steve J. Coats - Quakertown PA, US
Scott L. Dax - Landenberg PA, US
Bart DeCorte - Southhampton PA, US
Li Liu - Doylestown PA, US
Mark McDonnell - Lansdale PA, US
James J. McNally - Souderton PA, US
Assignee:

Janssen Pharmaceutica N.V. - Beerse
International Classification:

A61K 31/535
A61K 31/54
C07D 265/38
C07D 417/00
US Classification:

5142298, 544102, 544 42, 5142255
Abstract:

The invention is directed to delta opioid receptor modulators. More specifically, the invention relates to tricyclic δ-opioid modulators. Pharmaceutical and veterinary compositions and methods of treating mild to severe pain and various diseases using compounds of the invention are also described.

Tricyclic Δ- Opioid Modulators
view source
US Patent:

7439239, Oct 21, 2008
Filed:

Dec 21, 2005
Appl. No.:

11/313635
Inventors:

Steve Coats - Quakertown PA, US
Scott L. Dax - Landenberg PA, US
Bart DeCorte - Southhampton PA, US
Li Liu - Doylestown PA, US
Mark McDonnell - Lansdale PA, US
James J. McNally - Souderton PA, US
Assignee:

Janssen Pharmaceutica N.V. - Beerse
International Classification:

C07D 413/08
C07D 413/14
A61K 31/538
US Classification:

5142298, 544102
Abstract:

Disclosed are compounds, compositions and methods for treating various diseases and conditions, including pain. Such compounds are represented by Formula I as follows:.

Triazoles As Farnesyl Transferase Inhibitors
view source
US Patent:

7511061, Mar 31, 2009
Filed:

Jun 2, 2005
Appl. No.:

11/143814
Inventors:

Ashis Kumar Saha - Harleysville PA, US
David William End - Ambler PA, US
Bart Lieven Daniel De Corte - Southampton PA, US
Henry Joseph Breslin - Lansdale PA, US
Li Liu - Doylestown PA, US
Assignee:

Janssen Pharmaceutica N.V. - Beerse
International Classification:

A61K 31/4196
A61K 31/47
C07D 215/00
C07D 249/06
US Classification:

514311, 546112, 546152, 546169, 5482622, 5482676, 514383
Abstract:

A prodrug, N-oxide, addition salt, quaternary amine or stereochemically isomeric form thereof, wherein Land Lare R—Y— wherein each (R—Y)— substituent is defined independently of the other; Y is Calkanediyl, Calkenediyl, Calkynediyl, C(═O), or a direct bond; Ris hydrogen, cyano, aryl or a substituted or unsubstituted Cheterocycle; =Z-Z=Z- represents a radical of formula ═N—N═CH— (a-1), ═N—CH═N— (a-2), ═CH—N═N— (a-3); X is SO, (CH)wherein n is 1 to 4, C(═O), C(═S), or a direct bond; Ris aryl, Ccycloalkyl, Ccycloalkyl substituted with one or more substituents independently selected from hydroxy, aryl, aryloxy, a substituted or unsubstituted Cheterocycle, Ccycloalkyl, hydroxycarbonyl, Calkyloxycarbonyl, hydroxyCalkyl, hydroxyCalkyloxy, hydroxyCalkylthio and arylCalkylthio, Calkyl or Calkyl substituted with one or more substituents independently selected from hydroxy, aryl, aryloxy, a substituted or unsubstituted Cheterocycle, Ccycloalkyl, hydroxycarbonyl, Calkyloxycarbonyl, hydroxyCalkyl, hydroxyCalkyloxy, hydroxyCalkylthio and arylCalkylthio; Ris aryl, —NRR, a substituted or unsubstituted Cheterocycle, or Calkenediyl substituted with a substituted or unsubstituted Cheterocycle or aryl; Ris hydrogen, aryl, Ccycloalkyl, Calkyl or Calkyl substituted with Ccycloalkyl, hydroxycarbonyl, Calkyloxycarbonyl or aryl; Rand Rare each independently selected from hydrogen, a substituted or unsubstituted Cheterocycle, aryl, Calkyl and Calkyl substituted with one or more substituents selected from hydroxy, aryl, aryloxy or a substituted or unsubstituted Cheterocycle.

Tricyclic-Bridged Piperidinylidene Derivatives As Δ-Opioid Modulators
view source
US Patent:

7553850, Jun 30, 2009
Filed:

Aug 2, 2005
Appl. No.:

11/195231
Inventors:

Scott Dax - Landenberg PA, US
Bart DeCorte - Southhampton PA, US
Li Liu - Doylestown PA, US
Mark McDonnell - Lansdale PA, US
James McNally - Souderton PA, US
Assignee:

Janssen Pharmaceutica NV
International Classification:

A61K 31/46
US Classification:

514304, 546126
Abstract:

Disclosed are compounds, compositions and methods for treating various diseases and conditions, including pain. Such compounds are represented by Formula I as follows:.

Triazolopyrimidine Derivatives
view source
US Patent:

7563781, Jul 21, 2009
Filed:

Jan 11, 2006
Appl. No.:

11/329642
Inventors:

Donald W. Ludovici - Quakertown PA, US
Richard W. Connors - Harleysville PA, US
Steven J. Coats - Quakertown PA, US
Li Liu - Doylestown PA, US
Bart L. De Corte - Southampton PA, US
Dana L. Johnson - Upper Black Eddy PA, US
Mark J. Schulz - Skippack PA, US
Assignee:

Janssen Pharmaceutica NV
International Classification:

C07D 487/04
C07F 9/40
A61K 31/5355
A61K 31/519
C07D 239/30
A61P 35/00
G01N 33/53
C07H 21/04
C12P 21/06
C12N 5/06
C07K 16/40
C12N 9/12
US Classification:

514 81, 5142611, 5142342, 51425212, 544118, 544244, 544254, 544326, 544329, 435 71, 435 691, 435194, 435348, 536 232, 5303911
Abstract:

The invention relates to the discovery of triazolopyrimidine derivatives of formula (I), which have been found to exhibit inhibitory activity against the serine-tyrosine and tyrosine kinases.